Skip to content
OpenCapital
Get started

Denali Therapeutics Inc. DNLI Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Banner Corporation logo
Banner CorporationBANR
4.9%-0.2pp
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-791%-2,661pp
Griffon logo
GriffonGFF
5.9%-9.9pp
Benchmark Electronics logo
Benchmark ElectronicsBHE
3.8%-1.7pp
Establishment Labs logo
Establishment LabsESTA
-14.5%-5.0pp
Werner Enterprises logo
Werner EnterprisesWERN
1%-0.8pp

Other financials

Income statement

See full
Revenue-—
Operating income-$137.4M+5.6%
Net income-$128.4M+3.4%
EPS (diluted)-$0.69+11.5%

Balance sheet

See full
Cash & equivalents$390.7M+551%
Total debt$40.0M-22.3%
Total equity$926.1M-17.5%
Total assets$1.3B-0.4%

Cash flow

See full
Operating cash flow-$131.2M+0.2%
CapEx$2.5M-51.4%
Free cash flow-$133.7M+2.1%

Valuation

See full
Market cap$3.93B+54.2%

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-49.6%+34.2pp
Debt / equity0×0.0×
Current ratio9.3×-0.3×

Where this comes from

Calculated from Denali Therapeutics Inc.’s reported figures.

$40.0Mtotal debt+$926.1Mtotal stockholders equity−$390.7Mcash and equivalents=$575.41M

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Denali Therapeutics Inc.'s invested capital?
Denali Therapeutics Inc. (DNLI) reported invested capital of $575.41M in Q1 2026.
How has Denali Therapeutics Inc.'s invested capital changed year-over-year?
Denali Therapeutics Inc.'s invested capital decreased by 48.4% year-over-year, from $1.11B to $575.41M.
What is the long-term trend for Denali Therapeutics Inc.'s invested capital?
Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s invested capital has grown at a 3.6% compound annual growth rate (CAGR), from $710.75M to $847.7M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).